Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2

por Becker, J C, Terheyden, P, Kämpgen, E, Wagner, S, Neumann, C, Schadendorf, D, Steinmann, A, Wittenberg, G, Lieb, W, Bröcker, E-B
Publicado 2002

Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study

por Stege, H. M., Haist, M., Schultheis, S., Fleischer, M. I., Mohr, P., Ugurel, S., Terheyden, P., Thiem, A., Kiecker, F., Leiter, U., Becker, J. C., Meissner, M., Kleeman, J., Pföhler, C., Hassel, J., Grabbe, S., Loquai, C.
Publicado 2021

Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up

por D'Angelo, S.P., Bhatia, S., Brohl, A.S., Hamid, O., Mehnert, J.M., Terheyden, P., Shih, K.C., Brownell, I., Lebbé, C., Lewis, K.D., Linette, G.P., Milella, M., Xiong, H., Guezel, G., Nghiem, P.T.
Publicado 2021